AMA #67: Microplastics, PFAS, and phthalates: understanding health risks and a framework for minimizing exposure and mitigating risk

Peter Attia

Jan 20, 2025

Episode description

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

In this “Ask Me Anything” (AMA) episode, Peter tackles a topic that's been dominating headlines and sparking widespread concern: microplastics and plastic-associated chemicals, including BPA, PFAS, and phthalates. Peter explores the science behind these substances including how and why they've become so prevalent, the extent of our exposure, and the potential risks to our health. Most importantly, he provides a practical framework for understanding microplastics and plastic-associated chemicals and minimizing exposure while distinguishing genuine risks from exaggerated concerns.

If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #67 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

We discuss:

The complexity of the topic of microplastics and associated chemicals [1:30];
Definitions: microplastics, BPA, PM2.5, phthalates, and more [6:30];
The reasons behind the increase in microplastics in our environment and the surge in interest in them [12:00];
The various ways that humans are exposed to microplastics and nanoplastics [14:00];
Volume of plastic consumed by humans, and how the body eliminates or absorbs microplastics [16:00];
How microplastics accumulate in the body, the variability in tissue accumulation, and the challenges in studying their long-term health effects [21:30];
Limitations of blood tests for microplastics, and the importance of reliable biomarkers for guiding behavior and interventions [26:30];
The speculative health risks of microplastics, the limitations of current research, and the

Mindsip insights from this episode:

Focus on particle size to assess plastic risk

The primary concern with plastics is not the total mass consumed but the size of the particles, as only very small nanoplastics can be absorbed by the body.

#microplastics

#risk

Debunk myth of consuming a credit card's worth of plastic weekly

The popular claim that humans consume a credit card's worth of plastic (5 grams) per week has been largely debunked, with more realistic estimates being 10 to 300 micrograms.

#microplastics

Eliminate 99% of ingested microplastics through stool

Approximately 99% of ingested microplastics are eliminated through stool, as they have a very difficult time crossing the gastrointestinal barrier.

#digestion

#microplastics

Recognize inhaling plastic as direct bloodstream injection

Inhaling airborne particles smaller than 2.5 micrometers can allow them to cross into the bloodstream directly from the lungs, similar to being injected.

#microplastics

#pollution

Question safety of 'BPA-free' plastics due to substitutes

Plastics labeled 'BPA-free' are often made with substitutes like BPS and BPF, and it is not clear if these are any better for your health.

#BPA

#safety

Inspect shampoos for phthalate exposure

Your greatest exposure to phthalates, chemicals that make plastics flexible, likely comes from personal care products like shampoos and lotions where their use is largely unrestricted.

#phthalates

#toxin

Navigate complexities of microplastics for informed discussions

The topic of microplastics is so complex and filled with incomplete information that it was the most difficult and frustrating subject the host has ever prepared for an episode.

#microplastics

Peter Attia

#399 ‒ The evolution of Alzheimer's disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.

Building strength and muscle mass: how to optimize training, nutrition, and more for longevity (AMA #71 rebroadcast)

#398 ‒ AMA #86: GLP-1 RAs and muscle loss: new data, better questions, and how to preserve muscle during weight loss

#397 ‒ Endometriosis and adenomyosis: diagnosis, fertility, reproductive aging, and emerging treatments | Renato Tomioka, M.D., Ph.D.

#396 ‒ Breast cancer screening: understanding risk, deciding when to start and how often to screen, and choosing the right imaging strategy